Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYL-1701P in Diabetic Macular Edema Extension Study
NCT04674800Phase 3Completed
- Sponsor
- Mylan
- Start
- Nov 2020
- Primary completion
- Apr 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of M710 in diabetic macular edema (DME), sponsored by Mylan. Started Nov 2020; status: completed.
02
Drugs
M710
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04674800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674800.